-+ 0.00%
-+ 0.00%
-+ 0.00%
MindMaze Therapeutics Locks In Up to CHF4 Million Investments for Platform Deployment
Share
Listen to the news
01:23 AM EST, 11/17/2026 (MT Newswires) -- MindMaze Therapeutics (MMTX.SW) secured commitments of up to 4 million francs from long-term strategic investors to support the commercial deployment of its neurotherapeutics platform, according to a Tuesday release. The financing comprises shares and mandatory convertible notes of 0.12 franc apiece, as well as 7 million five-year warrants at 0.25 franc apiece. Subject to customary closing conditions, the Swiss neurotherapeutics company will receive 3 million francs of the commitments in November 2026 and December 2026, with the remaining 1 million francs subject to an investment option exercisable until Feb. 28, 2027. The investments will support its efforts to expand the company's customer base and expedite the growth of its revenue.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending